HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Debomoy K Lahiri Selected Research

Vaccinia virus N1L protein

11/2005The vaccinia virus N1L protein influences cytokine secretion in vitro after infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Debomoy K Lahiri Research Topics

Disease

117Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2002
24Amyloid Plaque
01/2022 - 01/2002
17Neurodegenerative Diseases (Neurodegenerative Disease)
07/2014 - 03/2002
13Neuroblastoma
12/2019 - 11/2002
11Inflammation (Inflammations)
10/2019 - 11/2002
9Neuroinflammatory Diseases
01/2019 - 12/2004
8Parkinson Disease (Parkinson's Disease)
06/2022 - 12/2004
7Dementia (Dementias)
12/2021 - 01/2002
7Stroke (Strokes)
11/2015 - 11/2002
6Autistic Disorder (Autism)
01/2019 - 06/2006
5Disease Progression
01/2022 - 07/2005
5Neoplasms (Cancer)
10/2019 - 11/2003
4Memory Disorders (Memory Loss)
09/2019 - 02/2010
3Hypoxia (Hypoxemia)
01/2018 - 12/2004
3Fragile X Syndrome (Martin Bell Syndrome)
01/2016 - 07/2013
3Type 2 Diabetes Mellitus (MODY)
01/2009 - 03/2002
2Bipolar Disorder (Manic Depressive Psychosis)
12/2019 - 05/2015
2Cognitive Dysfunction
09/2019 - 07/2009
2Autism Spectrum Disorder
01/2019 - 12/2014
2Infarction (Infarctions)
11/2015 - 03/2007
2Myasthenia Gravis
07/2012 - 07/2010
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2012 - 12/2004
2Erythema Nodosum
01/2004 - 11/2003
1Genomic Instability
10/2019

Drug/Important Bio-Agent (IBA)

51Proteins (Proteins, Gene)FDA Link
06/2022 - 03/2002
41Amyloid beta-PeptidesIBA
01/2017 - 01/2002
38Amyloid (Amyloid Fibrils)IBA
12/2021 - 05/2004
33Peptides (Polypeptides)IBA
01/2022 - 01/2002
19Pharmaceutical PreparationsIBA
10/2019 - 08/2002
12CytokinesIBA
01/2018 - 01/2004
9Amyloid Precursor Protein Secretases (beta-Secretase)IBA
03/2020 - 01/2006
7IronIBA
01/2013 - 11/2002
6Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2020 - 08/2003
6Messenger RNA (mRNA)IBA
01/2019 - 08/2002
6phenserineIBA
01/2018 - 12/2004
6Apolipoproteins E (ApoE)IBA
11/2015 - 01/2004
6Cholinergic Agents (Cholinergics)IBA
01/2014 - 11/2005
6Amyloid beta-Protein Precursor (Amyloid Protein Precursor)IBA
02/2010 - 10/2002
5tau Proteins (tau Protein)IBA
12/2021 - 04/2011
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 11/2003
5ApolipoproteinsIBA
01/2010 - 01/2004
5MetalsIBA
07/2009 - 08/2004
4Rivastigmine (Exelon)FDA LinkGeneric
03/2020 - 01/2002
4EnzymesIBA
02/2014 - 06/2004
4Glucagon-Like Peptide 1 (GLP 1)IBA
02/2014 - 03/2002
4Acetylcholine (Acetylcholine Chloride)FDA Link
01/2014 - 11/2005
4VaccinesIBA
06/2013 - 08/2004
45' Untranslated Regions (5' UTR)IBA
01/2013 - 08/2002
3Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2011
3Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
10/2021 - 01/2002
3LipopolysaccharidesIBA
01/2018 - 05/2012
3CholesterolIBA
11/2015 - 08/2004
3ButyrylcholinesteraseIBA
01/2014 - 01/2002
3Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2013 - 06/2006
3Glutamic Acid (Glutamate)FDA Link
07/2012 - 12/2004
3Memantine (Namenda)FDA Link
07/2012 - 01/2010
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2012 - 01/2010
3DNA (Deoxyribonucleic Acid)IBA
06/2012 - 11/2002
3Cholinesterases (Cholinesterase)IBA
07/2010 - 07/2005
3Glucagon-Like Peptide-1 ReceptorIBA
01/2010 - 03/2002
3Glucose (Dextrose)FDA LinkGeneric
01/2009 - 03/2002
3CopperIBA
12/2008 - 05/2004
3AcetylcholinesteraseIBA
07/2007 - 11/2005
3Neuroprotective AgentsIBA
01/2007 - 11/2002
3MelatoninIBA
11/2005 - 05/2004
3Vaccinia virus complement-control proteinIBA
12/2004 - 11/2002
3RNA (Ribonucleic Acid)IBA
01/2004 - 08/2002
2MicroRNAs (MicroRNA)IBA
01/2022 - 01/2012
2Biological ProductsIBA
10/2019 - 01/2012
2GlucocorticoidsIBA
01/2018 - 01/2018
2Amyloidogenic ProteinsIBA
01/2015 - 02/2005
2Acamprosate (Campral)FDA Link
12/2014 - 07/2013
2Intravenous Immunoglobulins (IVIG)FDA Link
07/2014 - 01/2014
2Glucagon-Like Peptide-1 Receptor AgonistsIBA
02/2014 - 12/2004
2Neurotransmitter Agents (Neurotransmitter)IBA
01/2014 - 11/2005
2Clioquinol (Vioform)FDA Link
06/2013 - 11/2002
2Transcription Factors (Transcription Factor)IBA
01/2013 - 12/2004
2N-Methylaspartate (NMDA)IBA
07/2012 - 01/2010
2ElementsIBA
06/2012 - 07/2009
2Exenatide (Byetta)FDA Link
01/2012 - 03/2002
2Membrane Proteins (Integral Membrane Proteins)IBA
05/2011 - 02/2006
2CurcuminIBA
01/2011 - 08/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2011 - 04/2006
2PhysostigmineIBA
07/2010 - 02/2005
2Chelating AgentsIBA
07/2009 - 11/2002
2Blood Glucose (Blood Sugar)IBA
01/2009 - 06/2003
2ZincIBA
12/2008 - 08/2004
2CarbamatesIBA
01/2007 - 02/2005
2Complement System Proteins (Complement)IBA
12/2004 - 11/2002
2Nitric Oxide Synthase (NO Synthase)IBA
12/2004 - 12/2004
2Thalidomide (Thalomid)FDA Link
01/2004 - 11/2003
1LithiumIBA
12/2019
1Tretinoin (Retinoic Acid)FDA LinkGeneric
12/2019
1Small Nucleolar RNA (snoRNA)IBA
12/2019
1Scopolamine (Hyoscine)FDA Link
09/2019
1AshwagandhaIBA
09/2019
1Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
09/2019
1DSP 4 (DSP-4)IBA
01/2019
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2019

Therapy/Procedure

9Therapeutics
01/2017 - 01/2002